Advertisement

Topics

RadioSurgery Partners Company Profile

08:48 EST 18th November 2017 | BioPortfolio


News Articles [143 Associated News Articles listed on BioPortfolio]

Stereotactic Radiosurgery After Complete Resection of Brain Mets Improves Outcomes

Postoperative stereotactic radiosurgery (SRS) reduces local recurrences with fewer adverse effects on cognitive function, according to results from two phase 3 trials. Reuters Health Information

Local Control of Brain Mets Improved With Stereotactic Radiosurgery

Patients with resected brain metastases who underwent stereotactic radiosurgery had lower rates of local recurrence compared with observation alone, according to the results of a phase III trial.

EU5 Radiosurgery Market Outlook to 2023 [Report Updated: 03072017] Prices from USD $5995

EU5 Radiosurgery Market Outlook to 2023SummaryGlobalData's new report, "EU5 Radiosurgery Market Outlook to 2023", provides key market data on the EU5 Radiosurgery market. The report provides value, in...

AsiaPacific Radiosurgery Market Outlook to 2023 [Report Updated: 03072017] Prices from USD $5995

AsiaPacific Radiosurgery Market Outlook to 2023SummaryGlobalData's new report, "AsiaPacific Radiosurgery Market Outlook to 2023", provides key market data on the AsiaPacific Radiosurgery market. The r...

BRIC Radiosurgery Market Outlook to 2023 [Report Updated: 03072017] Prices from USD $5995

BRIC Radiosurgery Market Outlook to 2023SummaryGlobalData's new report, "BRIC Radiosurgery Market Outlook to 2023", provides key market data on the BRIC Radiosurgery market. The report provides value,...

North America Radiosurgery Market Outlook to 2023 [Report Updated: 03072017] Prices from USD $5995

North America Radiosurgery Market Outlook to 2023SummaryGlobalData's new report, "North America Radiosurgery Market Outlook to 2023", provides key market data on the North America Radiosurgery market....

Early radiosurgery could make big difference to lives of patients with trigeminal neuralgia

Doctors should consider radiosurgery earlier for patients with severe facial pain, according to a new study in the International Journal of Radiation Oncology Biology Physics (the "Red Journal") - the...

[Articles] Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

Decline in cognitive function was more frequent with WBRT than with SRS and there was no difference in overall survival between the treatment groups. After resection of a brain metastasis, SRS radiosu...

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]

DAY CREAM MATTIFYING HYDRATOR

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [331 Associated PubMed Articles listed on BioPortfolio]

Stereotactic Radiosurgery in the Management of Limited (1-4) Brain Metasteses: Systematic Review and International Stereotactic Radiosurgery Society Practice Guideline.

Guidelines regarding stereotactic radiosurgery (SRS) for brain metastases are missing recently published evidence.

Partners' Overestimation of Patients' Pain Severity: Relationships with Partners' Interpersonal Responses.

The present study examined whether concordance between patients' and their partners' reports of patient pain severity relates to partners' social support and behavioral responses in couples coping wit...

Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma.

The effectiveness of stereotactic radiosurgery (SRS) for recurrent glioblastoma (rGBM) remains uncertain. SRS has been associated with a high risk of radionecrosis in gliomas.

Design of a modulated orthovoltage stereotactic radiosurgery system.

To achieve stereotactic radiosurgery (SRS) dose distributions with sharp gradients using orthovoltage energy fluence modulation with inverse planning optimization techniques.

Stereotactic Radiosurgery for the Treatment of Chronic Intractable Pain: A Systematic Review.

Since the advent of neuromodulation, the role and efficacy of stereotactic radiosurgery (SRS) for chronic pain has not been carefully scrutinized.

Clinical Trials [401 Associated Clinical Trials listed on BioPortfolio]

Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases

RATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. Giving stereotactic radiosurgery after surgery may kill any tu...

Resection Bed Post-Surgical Stereotactic Radiosurgery (SRS)

The goal of this clinical research study is to learn if stereotactic radiosurgery can help to reduce the risk of a brain tumor returning after surgery. The safety of this treatment will al...

Stereotactic Radiosurgery (SRS) for Multiple CNS Mets

This study is designed to determine outcome for patients with 5 or more central nervous system (CNS) metastatic lesions treated with stereotactic radiosurgery (SRS).

Stereotactic Radiosurgery in Treating Patients With Brain Metastases

RATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. Giving stereotactic radiosurgery before surgery may make the t...

Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Radiosurgery may be able to deliver x-rays directly to the tumor and cause less damage to normal tissue. It is n...

Companies [897 Associated Companies listed on BioPortfolio]

Accuray

Accuray's history began when John R. Adler, MD, professor of neurosurgery and radiation oncology at Stanford University Medical Center, developed the CyberKnife® System in 1987 after completing a fel...

RadioSurgery Partners

Accuray Incorporated

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option ...

Alliance Oncology

Alliance Oncology partners with hospitals and radiation oncologists to set a new standard of care for cancer patients. This is achieved through the establishment of state-of-the-a...

Cromwell Hospital

The Cromwell Hospital in London provides healthcare facilities for UK and overseas patients. Major specialities include cancer treatment, liver disease and transplant, neurosurgery, spinal surgery, he...

More Information about "RadioSurgery Partners" on BioPortfolio

We have published hundreds of RadioSurgery Partners news stories on BioPortfolio along with dozens of RadioSurgery Partners Clinical Trials and PubMed Articles about RadioSurgery Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of RadioSurgery Partners Companies in our database. You can also find out about relevant RadioSurgery Partners Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record